These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 24898559)

  • 21. 5α-Reductase inhibitors in androgenetic alopecia.
    Yim E; Nole KL; Tosti A
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):493-8. PubMed ID: 25268732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.
    Dhurat R; Sharma A; Rudnicka L; Kroumpouzos G; Kassir M; Galadari H; Wollina U; Lotti T; Golubovic M; Binic I; Grabbe S; Goldust M
    Dermatol Ther; 2020 May; 33(3):e13379. PubMed ID: 32279398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia.
    Tsunemi Y; Irisawa R; Yoshiie H; Brotherton B; Ito H; Tsuboi R; Kawashima M; Manyak M;
    J Dermatol; 2016 Sep; 43(9):1051-8. PubMed ID: 26893187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.
    Kang MJ; Choi JY; Sim WY; Lew BL
    J Am Acad Dermatol; 2021 Jan; 84(1):172-173. PubMed ID: 32320771
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study.
    Eun HC; Kwon OS; Yeon JH; Shin HS; Kim BY; Ro BI; Cho HK; Sim WY; Lew BL; Lee WS; Park HY; Hong SP; Ji JH
    J Am Acad Dermatol; 2010 Aug; 63(2):252-8. PubMed ID: 20605255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia.
    Kang HW; Chae MH; Park SH; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Yoon TY; Kim WJ
    J Urol; 2017 Dec; 198(6):1340-1345. PubMed ID: 28743526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Caspase-1 level is higher in the scalp in androgenetic alopecia.
    de Rivero Vaccari JP; Sawaya ME; Brand F; Nusbaum BP; Bauman AJ; Bramlett HM; Dietrich WD; Keane RW
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy and safety of dutasteride 0.5 mg in Korean men with androgenetic alopecia: 5-year data demonstrating clinical improvement with sustained efficacy.
    Choi S; Kwon SH; Sim WY; Lew BL
    J Dermatol; 2024 May; 51(5):684-690. PubMed ID: 38321615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair.
    Hobo Y; Nishikawa J; Taniguchi Asai N; Yoneyama K; Watanabe Y; Miyashiro Y; Fujikata A
    Clin Chim Acta; 2023 Jul; 547():117456. PubMed ID: 37385468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonsurgical therapy for hair loss.
    Nusbaum AG; Rose PT; Nusbaum BP
    Facial Plast Surg Clin North Am; 2013 Aug; 21(3):335-42. PubMed ID: 24017975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men's Health.
    Said MA; Mehta A
    Curr Urol Rep; 2018 Jun; 19(8):65. PubMed ID: 29909472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finasteride in the treatment of Japanese men with male pattern hair loss.
    Kawashima M; Hayashi N; Igarashi A; Kitahara H; Maeguchi M; Mizuno A; Murata Y; Nogita T; Toda K; Tsuboi R; Ueki R; Yamada M; Yamazaki M; Matsuda T; Natsumeda Y; Takahashi K; Harada S
    Eur J Dermatol; 2004; 14(4):247-54. PubMed ID: 15319158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.
    Rossi A; Cantisani C; Scarnò M; Trucchia A; Fortuna MC; Calvieri S
    Dermatol Ther; 2011; 24(4):455-61. PubMed ID: 21910805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms.
    Ganzer CA; Jacobs AR; Iqbal F
    Am J Mens Health; 2015 May; 9(3):222-8. PubMed ID: 24928450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
    Coskuner ER; Ozkan B; Culha MG
    Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
    Belknap SM; Aslam I; Kiguradze T; Temps WH; Yarnold PR; Cashy J; Brannigan RE; Micali G; Nardone B; West DP
    JAMA Dermatol; 2015 Jun; 151(6):600-6. PubMed ID: 25830296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study.
    Rossi A; Mari E; Scarno M; Garelli V; Maxia C; Scali E; Iorio A; Carlesimo M
    Int J Immunopathol Pharmacol; 2012; 25(4):1167-73. PubMed ID: 23298508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexual dysfunction with 5-alpha-reductase inhibitor therapy for androgenetic alopecia: A global propensity score matched retrospective cohort study.
    Lauck KC; Limmer A; Harris P; Kivelevitch D
    J Am Acad Dermatol; 2024 Jul; 91(1):163-166. PubMed ID: 38552905
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.